AT405277T
Substitution infusion fluid and citrate anticoagulation
Abstract
This record has no abstract on file.
Term
Term ended
Expired 20 April 2020, 6.4 years ago.
- Priority
- Filed
- Granted
- Expired
- Today
45 members in 13 offices
Priority claims4
| Document | Office | Kind | Date |
|---|---|---|---|
| 99201302 | European Patent Office (EPO) | A | |
| 99201302 | European Patent Office (EPO) | A | |
| 99201302 | – | – | – |
| EP19990201302 | – | – | – |
Members45
| Document | Office | Kind | |
|---|---|---|---|
| WO0064456A2 | World Intellectual Property Organization (WIPO) | A2 | |
| AU4553700A | Australia | A | |
| WO0064456A3 | World Intellectual Property Organization (WIPO) | A3 | |
| EP1176969A2 | European Patent Office (EPO) | A2 | |
| US6743191B1 | United States of America | B1 | |
| US2004129638A1 | United States of America | A1 | |
| US7186420B2 | United States of America | B2 | |
| US2007062861A1 | United States of America | A1 | |
| CA2630798A1 | Canada | A1 | |
| WO2007062197A1 | World Intellectual Property Organization (WIPO) | A1 | |
| US2007134348A1 | United States of America | A1 | |
| EP1176969B1 | European Patent Office (EPO) | B1 | |
| AT405277TThis record | Austria | T | |
| ATE405277T1 | Austria | T1 | |
| DE60039978D1 | Germany | D1 | |
| EP2001532A1 | European Patent Office (EPO) | A1 | |
| ES2315228T3 | Spain | T3 | |
| JP2009516575A | Japan | A | |
| US7758900B2 | United States of America | B2 | |
| US2010301268A1 | United States of America | A1 | |
| EP2324871A2 | European Patent Office (EPO) | A2 | |
| US8105258B2 | United States of America | B2 | |
| US2012045364A1 | United States of America | A1 | |
| US8158157B2 | United States of America | B2 | |
| US2012123314A1 | United States of America | A1 | |
| US8216172B2 | United States of America | B2 | |
| JP5023071B2 | Japan | B2 | |
| EP2324871A3 | European Patent Office (EPO) | A3 | |
| EP2001532B1 | European Patent Office (EPO) | B1 | |
| ES2421616T3 | Spain | T3 | |
| US8529486B2 | United States of America | B2 | |
| US2013323122A1 | United States of America | A1 | |
| CA2630798C | Canada | C | |
| US8795517B2 | United States of America | B2 | |
| EP2324871B1 | European Patent Office (EPO) | B1 | |
| PT2324871T | Portugal | T | |
| DK2324871T3 | Denmark | T3 | |
| SI2324871T1 | Slovenia | T1 | |
| ES2592955T3 | Spain | T3 | |
| PL2324871T3 | Poland | T3 | |
| EP2324871B2 | European Patent Office (EPO) | B2 | |
| DK2324871T4 | Denmark | T4 | |
| PL2324871T5 | Poland | T5 | |
| SI2324871T2 | Slovenia | T2 | |
| ES2592955T5 | Spain | T5 |
1 legal event, as the office reported them to INPADOC
Events
| Event | Code | |
|---|---|---|
| Ceased as to paragraph 5 lit. 3 law introducing patent treatiesCeasedRER | RER |
Numbers
- Publication, DOCDB
- 405277
- Publication, EPODOC
- AT405277T
- Application
- 927004
- Application, DOCDB
- 00927004
- Application, EPODOC
- AT20000927004T
Titles2
- German
- SUBSTITUTIONS-INFUSIONFLÜSSIGKEIT UND ZITRATANTICOAGULATION
- English
- SUBSTITUTION INFUSION FLUID AND CITRATANTICOAGULATION
Classification
- CPC, 7
- A61M1/3672
- A61K33/42
- A61M1/3455
- A61M1/3675
- A61M1/3437
- A61M1/3458
- A61P7/08
- IPC, 8
- A61K33 42
- A61K31 70
- A61K33 06
- A61K33 14
- A61K38 18
- A61M1 34
- A61M1 36
- A61P7 08